What Verition Fund Management LLC changed, 2013 to 2026
53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.
Reported book
$19.7bn
$545m at Q2 2013
Positions
2,055
552 at Q2 2013
Top ten weight
25%
29% at Q2 2013
Typical quarterly turnover
about 38%
Estimated from share changes
- Q2 2013: $545m
- Q3 2013: $661m
- Q4 2013: $563m
- Q1 2014: $657m
- Q2 2014: $935m
- Q3 2014: $709m
- Q4 2014: $446m
- Q1 2015: $861m
- Q2 2015: $571m
- Q3 2015: $384m
- Q4 2015: $525m
- Q1 2016: $619m
- Q2 2016: $784m
- Q3 2016: $932m
- Q4 2016: $1.2bn
- Q1 2017: $1.1bn
- Q2 2017: $1.0bn
- Q3 2017: $1.2bn
- Q4 2017: $1.1bn
- Q1 2018: $1.3bn
- Q2 2018: $1.6bn
- Q3 2018: $2.8bn
- Q4 2018: $1.4bn
- Q1 2019: $2.6bn
- Q2 2019: $3.6bn
- Q3 2019: $3.6bn
- Q4 2019: $5.5bn
- Q1 2020: $2.5bn
- Q2 2020: $3.0bn
- Q3 2020: $5.0bn
- Q4 2020: $11.4bn
- Q1 2021: $8.9bn
- Q2 2021: $11.0bn
- Q3 2021: $11.5bn
- Q4 2021: $13.9bn
- Q1 2022: $8.3bn
- Q2 2022: $5.1bn
- Q3 2022: $8.9bn
- Q4 2022: $6.4bn
- Q1 2023: $7.2bn
- Q2 2023: $7.5bn
- Q3 2023: $8.6bn
- Q4 2023: $12.8bn
- Q1 2024: $14.6bn
- Q2 2024: $18.3bn
- Q3 2024: $19.9bn
- Q4 2024: $25.3bn
- Q1 2025: $21.5bn
- Q2 2025: $22.5bn
- Q3 2025: $24.2bn
- Q4 2025: $25.5bn
- Q1 2026: $15.4bn
- Q2 2026: $19.7bn
- Q2 2013: 29%
- Q3 2013: 33%
- Q4 2013: 40%
- Q1 2014: 45%
- Q2 2014: 45%
- Q3 2014: 40%
- Q4 2014: 56%
- Q1 2015: 77%
- Q2 2015: 37%
- Q3 2015: 17%
- Q4 2015: 29%
- Q1 2016: 19%
- Q2 2016: 16%
- Q3 2016: 13%
- Q4 2016: 18%
- Q1 2017: 15%
- Q2 2017: 23%
- Q3 2017: 16%
- Q4 2017: 21%
- Q1 2018: 12%
- Q2 2018: 15%
- Q3 2018: 26%
- Q4 2018: 24%
- Q1 2019: 31%
- Q2 2019: 32%
- Q3 2019: 34%
- Q4 2019: 33%
- Q1 2020: 35%
- Q2 2020: 29%
- Q3 2020: 36%
- Q4 2020: 38%
- Q1 2021: 43%
- Q2 2021: 33%
- Q3 2021: 34%
- Q4 2021: 27%
- Q1 2022: 10%
- Q2 2022: 7%
- Q3 2022: 7%
- Q4 2022: 10%
- Q1 2023: 11%
- Q2 2023: 9%
- Q3 2023: 9%
- Q4 2023: 33%
- Q1 2024: 18%
- Q2 2024: 28%
- Q3 2024: 19%
- Q4 2024: 22%
- Q1 2025: 20%
- Q2 2025: 11%
- Q3 2025: 15%
- Q4 2025: 25%
- Q1 2026: 21%
- Q2 2026: 25%
The positions that defined it
Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.
| Position | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| iShares Core S&P500 ETF(IVV) | Q3 2017 | $1.6bnQ4 2024 | $1.4bn | |
| Invesco QQQ Trust(QQQ) | Q1 2019 | $711mQ2 2026 | $711m | |
| Spdr S&P 500 Etf Trust(SPY) | Q2 2013 | $1.3bnQ4 2023 | $689m | |
| Invesco QQQ Trust(QQQ) | Q1 2020 | $644mQ2 2026 | $644m | |
| Spdr S&P 500 Etf Trust(SPY) | Q2 2013 | $1.3bnQ4 2023 | $284m | |
| Warner Bros Discovery Inc(WBD)Common Series A | Q4 2024 | $245mQ4 2025 | $241m | |
| Norfolk Southern Corp(NSC) | Q2 2013 | $239mQ2 2026 | $239m | |
| VanEck Vectors Semiconductor(SMH) | Q1 2022 | $225mQ2 2026 | $225m | |
| Invesco QQQ Trust(QQQ) | Q4 2018 | $221mQ2 2026 | $221m | |
| Electronic Arts Inc(EA) | Q2 2013 | $219mQ2 2026 | $219m | |
| Select Med HLDGS Corp(SEM) | Q2 2026 | $199mQ2 2026 | $199m | |
| iShares 20 Year Treasury Bond ETF(TLT) | Q1 2021 | $196mQ2 2026 | $196m | |
| Tesla MTRS Inc(TSLA) | Q4 2015 | $601mQ4 2025 | Soldlast listed Q1 2026 | |
| Select Sector SPDR CON(XLP) | Q1 2026 | $591mQ1 2026 | Below the listed rangelast listed Q1 2026 | |
| Salix Pharmaceuticals Inc | Q1 2015 | $482mQ1 2015 | Soldlast listed Q1 2015 | |
| Boeing Co(BA) | Q3 2013 | $439mQ1 2021 | Soldlast listed Q1 2022 | |
| Xilinx Inc | Q4 2020 | $434mQ4 2021 | Soldlast listed Q4 2021 | |
| Fortive Corp(FTV) | Q3 2018 | $373mQ3 2018 | Soldlast listed Q3 2018 | |
| Xilinx Inc | Q4 2020 | $373mQ4 2021 | Soldlast listed Q4 2021 | |
| Netflix Inc(NFLX) | Q2 2014 | $314mQ4 2020 | Soldlast listed Q1 2026 |
Quarter by quarter
Q4 2014: $446m across 338 positions
Against Q3 2014: 177 new, 45 added to, 100 trimmed, 515 sold out, across all 338 positions.
Turnover about 48% of the book, estimated from share changes at quarter-end prices.
Largest additions
- Covance Inc+$48m
- SPDR Series DB INT GVT ETF (WIP)+$6.1m
- Take-two Interactive Softwar+$3.3m
- Chinacache Intl HLDG LTD+$3.0m
- Advisorshares TR+$2.7m
- Pimco 0-5 High Yield (HYS)+$2.4m
- iShares JPMorgan USD (EMB)+$1.9m
- Verint Sys Inc+$1.5m
Largest reductions
- iShares Ftse China25 Index (FXI)-$6.3m
- Albemarle Corp (ALB)-$5.5m
- Chinacache Intl HLDG LTD-$5.1m
- Oracle Corp (ORCL)-$3.6m
- Spdr S&P 500 Etf Trust (SPY)-$2.7m
- iShares MSCI Spain (EWP)-$1.9m
- Hewlett Packard Co-$1.6m
- Waters Corp (WAT)-$1.4m
Opened
- TRW Automotive HLDGS Corp$60m
- United States Oil Fund LP$18m
- Avanir Pharmaceuticals Inc$12m
- Vipshop HLDGS LTD$8.4m
- Medivation Inc$6.8m
- Incyte Corp$6.1m
- iShares High YLD Corp (HYG)$5.8m
- Tesla MTRS Inc$4.6m
Sold out
- Akorn Incwas $57m
- Family DLR Stores Incwas $24m
- Biomarin Pharmaceutical Incwas $8.5m
- Medicines Cowas $6.4m
- Home Inns & Hotels MGMT Incwas $6.0m
- Yandex, NVwas $5.3m
- Molina Healthcare Incwas $3.7m
- Netsuite Incwas $3.7m
Largest positions, Q4 2014
The largest 25 of 338 reported positions.
| Position | Value | Weight | On the quarter |
|---|---|---|---|
| TRW Automotive HLDGS Corp | $60m | 13.5% | New |
| Rockwood HLDGS Inc | $57m | 12.8% | Trimmed |
| Covance Inc | $50m | 11.2% | Added |
| United States Oil Fund LP | $18m | 4.1% | New |
| Qihoo 360 Technology Co LTD | $17m | 3.8% | Held |
| Avanir Pharmaceuticals Inc | $12m | 2.7% | New |
| Salix Pharmaceuticals Inc | $10m | 2.3% | Added |
| Chinacache Intl HLDG LTD | $9.2m | 2.1% | Added |
| Solarcity Corp | $8.7m | 1.9% | Held |
| Vipshop HLDGS LTD | $8.4m | 1.9% | New |
| Accuray Inc | $7.9m | 1.8% | Held |
| Medivation Inc | $6.8m | 1.5% | New |
| SPDR Series DB INT GVT ETF (WIP) | $6.4m | 1.4% | Added |
| Incyte Corp | $6.1m | 1.4% | New |
| iShares High YLD Corp (HYG) | $5.8m | 1.3% | New |
| Take-two Interactive Softwar | $5.3m | 1.2% | Added |
| Advisorshares TR | $5.0m | 1.1% | Added |
| Tesla MTRS Inc | $4.6m | 1.0% | New |
| Electronic Arts Inc | $4.5m | 1.0% | New |
| Opko Health Inc (OPK) | $4.0m | 0.9% | Held |
| Tesaro Inc | $3.8m | 0.8% | New |
| Cubist Pharmaceuticals Inc | $3.4m | 0.8% | New |
| Google Inc | $3.1m | 0.7% | New |
| Pimco 0-5 High Yield (HYS) | $3.0m | 0.7% | Added |
| Spdr S&P 500 Etf Trust (SPY) | $3.0m | 0.7% | Trimmed |
The books most like this one
Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.
| Manager | Overlap | Stocks in both | Overlap over time | |
|---|---|---|---|---|
| Bridgewater Associates LP | at least 21% | 122 | Compare | |
| Marshall Wace LLP | at least 19% | 120 | Compare | |
| Schonfeld Strategic Advisors LLC | at least 18% | 129 | Compare | |
| Walleye Capital LLC | at least 18% | 109 | Compare | |
| Balyasny Asset Management LLC | at least 18% | 147 | Compare | |
| Squarepoint Ops LLC | at least 17% | 103 | Compare | |
| Freestone Grove Partners LP | at least 16% | 117 | Compare | |
| Millennium Management LLC | at least 16% | 126 | Compare |
“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.
The filings behind it
Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.
| Quarter | Filer | Book | Amended | Filing |
|---|---|---|---|---|
| Q2 2026 | Verition Fund Management LLC | $19.7bn | 13F-HR | |
| Q1 2026 | Verition Fund Management LLC | $15.4bn | 13F-HR | |
| Q4 2025 | Verition Fund Management LLC | $25.5bn | 13F-HR | |
| Q3 2025 | Verition Fund Management LLC | $24.2bn | 13F-HR | |
| Q2 2025 | Verition Fund Management LLC | $22.5bn | 13F-HR | |
| Q1 2025 | Verition Fund Management LLC | $21.5bn | 13F-HR | |
| Q4 2024 | Verition Fund Management LLC | $25.3bn | 13F-HR | |
| Q3 2024 | Verition Fund Management LLC | $19.9bn | 13F-HR | |
| Q2 2024 | Verition Fund Management LLC | $18.3bn | 13F-HR | |
| Q1 2024 | Verition Fund Management LLC | $14.6bn | 13F-HR | |
| Q4 2023 | Verition Fund Management LLC | $12.8bn | 13F-HR | |
| Q3 2023 | Verition Fund Management LLC | $8.6bn | 13F-HR | |
| Q2 2023 | Verition Fund Management LLC | $7.5bn | 13F-HR | |
| Q1 2023 | Verition Fund Management LLC | $7.2bn | 13F-HR | |
| Q4 2022 | Verition Fund Management LLC | $6.4bn | 13F-HR | |
| Q3 2022 | Verition Fund Management LLC | $8.9bn | 1 | 13F-HR |
| Q2 2022 | Verition Fund Management LLC | $5.1bn | 13F-HR | |
| Q1 2022 | Verition Fund Management LLC | $8.3bn | 13F-HR | |
| Q4 2021 | Verition Fund Management LLC | $13.9bn | 13F-HR | |
| Q3 2021 | Verition Fund Management LLC | $11.5bn | 13F-HR | |
| Q2 2021 | Verition Fund Management LLC | $11.0bn | 13F-HR | |
| Q1 2021 | Verition Fund Management LLC | $8.9bn | 13F-HR | |
| Q4 2020 | Verition Fund Management LLC | $11.4bn | 1 | 13F-HR |
| Q3 2020 | Verition Fund Management LLC | $5.0bn | 13F-HR | |
| Q2 2020 | Verition Fund Management LLC | $3.0bn | 13F-HR | |
| Q1 2020 | Verition Fund Management LLC | $2.5bn | 13F-HR | |
| Q4 2019 | Verition Fund Management LLC | $5.5bn | 13F-HR | |
| Q3 2019 | Verition Fund Management LLC | $3.6bn | 13F-HR | |
| Q2 2019 | Verition Fund Management LLC | $3.6bn | 13F-HR | |
| Q1 2019 | Verition Fund Management LLC | $2.6bn | 13F-HR | |
| Q4 2018 | Verition Fund Management LLC | $1.4bn | 13F-HR | |
| Q3 2018 | Verition Fund Management LLC | $2.8bn | 13F-HR | |
| Q2 2018 | Verition Fund Management LLC | $1.6bn | 13F-HR | |
| Q1 2018 | Verition Fund Management LLC | $1.3bn | 13F-HR | |
| Q4 2017 | Verition Fund Management LLC | $1.1bn | 13F-HR | |
| Q3 2017 | Verition Fund Management LLC | $1.2bn | 13F-HR | |
| Q2 2017 | Verition Fund Management LLC | $1.0bn | 13F-HR | |
| Q1 2017 | Verition Fund Management LLC | $1.1bn | 13F-HR | |
| Q4 2016 | Verition Fund Management LLC | $1.2bn | 13F-HR | |
| Q3 2016 | Verition Fund Management LLC | $932m | 13F-HR | |
| Q2 2016 | Verition Fund Management LLC | $784m | 13F-HR | |
| Q1 2016 | Verition Fund Management LLC | $619m | 13F-HR | |
| Q4 2015 | Verition Fund Management LLC | $525m | 13F-HR | |
| Q3 2015 | Verition Fund Management LLC | $384m | 13F-HR | |
| Q2 2015 | Verition Fund Management LLC | $571m | 13F-HR | |
| Q1 2015 | Verition Fund Management LLC | $861m | 13F-HR | |
| Q4 2014 | Verition Fund Management LLC | $446m | 13F-HR | |
| Q3 2014 | Verition Fund Management LLC | $709m | 13F-HR | |
| Q2 2014 | Verition Fund Management LLC | $935m | 13F-HR | |
| Q1 2014 | Verition Fund Management LLC | $657m | 13F-HR | |
| Q4 2013 | Verition Fund Management LLC | $563m | 13F-HR | |
| Q3 2013 | Verition Fund Management LLC | $661m | 13F-HR | |
| Q2 2013 | Verition Fund Management LLC | $545m | 13F-HR |
Reading this record
A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More